Editorial Board
Antonio Russo
Professor
Department of Surgical,Oncological & Stomatological Sciences
University of PalermoMedical School
Italy
Biography
Dr. Antonio Russo is a Professor in the Department of Surgical, Oncological, and Stomatological Sciences. He also served as an Adjunct Associate Professor at Temple University’s College of Science and Technology, Philadelphia, Pennsylvania, USA.
He previously served as Director of the Specialization School in Medical Oncology at the University of Palermo, Italy. The Medical Oncology Unit directed by Prof. A. Russo has been recognized as an ESMO Designated Centre of Integrated Oncology and Palliative Care.
His areas of expertise include the design and conduct of Phase II–III clinical trials in solid tumors, chemotherapy, and targeted therapies for solid tumors. He was awarded a specialization in Medical Genetics from the University of Catania, Italy.
Marco Agostini
Research Scientist
Department of Surgical oncology and Gastroenterological Science
University of Padova
Padova
Italy
Biography
Dr. Marco Agostini is a Research Scientist in the Department of Surgical Oncology and Gastroenterological Science at the University of Padova, Padova, Italy. He previously worked as an Assistant Professor in the Department of Oncology and Surgical Sciences at the University of Padova.
He received his Ph.D. in Genetic and Molecular Characterization of Cancer from the University of Padova, with a focus on genetic pathways underlying the progression and outcomes of colon cancer, as well as drug delivery system modulation.
His research focuses on the discovery of new molecular markers for the non-invasive early detection of cancer through liquid biopsies, and on identifying the roles of circulating molecular markers in tumor response and patient outcomes, particularly in rectal cancer patients undergoing pre-operative chemoradiotherapy. His work also includes circulating microRNAs and the circulating peptidome.
Dr. Agostini holds a patent for an in vitro method for the diagnosis, prognosis, and treatment of cancer through the analysis of body fluid samples, including total circulating DNA and DNA released by non-apoptotic cells.
Tianhui Chen
Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou, 310022, CHINA
Research Interests:
Clinical epidemiology, molecular epidemiology, and genetic epidemiology, with a focus on familial cancers, including colorectal, breast, ovarian, and pancreatic cancers.
Peng Luo
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, CHINA
Research Interests:
Cancer biology, clinical oncology, lung diseases, cancer diagnostics, metastasis, tumor markers, cancer immunology, and disease prognosis and diagnosis.
Giandomenico Roviello
Section of Clinical Pharmacology and Oncology, Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, 50139, ITALY
Research Interests:
Renal cell carcinoma, targeted therapies, immunotherapy, breast cancer, therapeutic inhibitors, urothelial carcinoma, and genitourinary oncology.
Raffaele Manni, MD
Professor of Pharmacology and Oncology
Neurologist at the National Institute of Neurology
C. Mondino” of Pavia, Pavia, Italy